Clear ARB Mechanism
Telmisartan is a well-recognized angiotensin II receptor blocker with a clearly defined mechanism of action. Its pharmacological role has been extensively studied, providing a solid background for use in pharmaceutical products related to blood-pressure regulation.
Consistent Formulation Behavior
With a defined molecular structure and stable physicochemical properties, telmisartan shows predictable performance during formulation and processing. This supports its application in finished dosage form development and formulation optimization.
Suitable for Regulated Development
This material is commonly used in pharmaceutical projects that require compliance with regulatory and development standards. Its established profile supports generic drug development and registration-oriented work.
Stable Quality Profile
Controlled by standard analytical methods, telmisartan powder offers consistent batch quality. This reliability supports routine testing, quality evaluation, and long-term supply planning.
COA
|
|
||
|
Product Name |
CAS Number |
Batch Number |
|
telmisartan powder |
144701-48-4 |
MB2601191030 |
|
Manufacturer Date |
Analysis Date |
Expiry Date |
|
2026-01-19 |
2026-01-20 |
2028-01-18 |
|
Sample Qty Base |
Packing |
Test Method |
|
500KGS |
25kg/drum |
HPLC |
|
Item |
Standard |
Results |
|
Aρpearance |
White Powder |
Conforms |
|
Odor |
Characteristic |
Conforms |
|
Assay |
≥99% |
99.71% |
|
Melting point |
261~263℃ |
261.3℃ |
|
Loss on drying |
≤5.0% |
2.38% |
|
Ash |
≤5.0% |
2.65% |
|
Heavy Metals |
≤10ppm |
Conforms |
|
As |
≤1ppm |
Conforms |
|
Pb |
≤2ppm |
Conforms |
|
Hg |
≤0.1ppm |
Conforms |
|
Cd |
≤1ppm |
Conforms |
|
Total Plate Count |
≤1000cfu/g |
Conforms |
|
Yeast & Mold |
≤100cfu/g |
Conforms |
|
Salmonella |
Negative |
Negative |
|
E.Coli |
Negative |
Negative |
|
Residue pesticide |
Negative |
Negative |
|
Storage |
Store in cool & dry place. keep away from strong light and heat |
|
|
Conclusion |
The batch conforms to the IN-HOUSE standard |
|
|
|
||
How Telmisartan Works in Formulations
Telmisartan functions as an angiotensin II receptor blocker by selectively interacting with angiotensin II type 1 (AT₁) receptors. Through this interaction, it interferes with receptor-mediated signaling pathways associated with vascular tone. This mechanism has been widely studied and forms the basis for its use in pharmaceutical formulations related to blood-pressure regulation.
What It Is Used For in Pharmaceutical Products
In pharmaceutical development, telmisartan is used as an active ingredient in formulations designed for blood-pressure-related indications. Its role in these products is supported by a clearly defined molecular structure and a well-documented pharmacological background. Because its performance and behavior are predictable, it is commonly selected for finished dosage form development as well as generic and registration-driven projects.
Role of Telmisartan in a Pharmaceutical System
Within a pharmaceutical formulation system, telmisartan functions as a core active ingredient responsible for modulating angiotensin II–mediated signaling pathways. Its role is not defined by standalone use, but by how it integrates into a controlled dosage form designed for long-term and consistent delivery.
From a formulation perspective, telmisartan is selected for its well-characterized molecular behavior and stable interaction with common excipient systems. Its low aqueous solubility and defined receptor interaction profile allow formulation teams to design dosage forms with predictable performance across production and scale-up stages.
In the broader development system, telmisartan serves as a reference ARB compound with an established pharmacological background. This allows development and quality teams to focus on formulation design, process control, and consistency management, rather than uncertainty at the active ingredient level. Its position in the system is therefore linked to reliability, repeatability, and regulatory familiarity rather than experimental exploration.
Telmisartan API vs Other Antihypertensive APIs
|
Comparison Aspect |
Telmisartan |
Losartan |
Valsartan |
|
Role in System |
Core ARB API designed for stable, long-term system integration |
ARB API often used in more flexible or short-duration systems |
ARB API commonly applied in conventional IR systems |
|
System Positioning |
Treated as a "known constant" within regulated pharmaceutical systems |
Allows greater formulation latitude but less emphasis on sustained system behavior |
Fits well into standardized, widely adopted formulation frameworks |
|
Receptor Interaction Profile |
Characterized by sustained AT₁ receptor interaction |
Shorter receptor interaction profile |
Intermediate receptor interaction behavior |
|
Formulation Strategy Impact |
Supports designs focused on consistency and long-term performance |
Supports simpler or more adaptable formulation strategies |
Supports established, repeatable formulation approaches |
|
Development Focus |
Long-term planning, regulatory familiarity, batch consistency |
Development speed and formulation flexibility |
Balance between standardization and scalability |
|
Typical Project Use |
Mature products, generic replication, registration-driven programs |
Projects prioritizing rapid development or formulation adjustment |
Large-scale manufacturing with proven formulation routes |
Use & Storage Considerations
Telmisartan powder is intended for professional and industrial use only. It should be handled using standard practices applicable to pharmaceutical active ingredients, with care taken to avoid unnecessary exposure during routine weighing and transfer operations.
For storage, the material should be kept in tightly sealed containers and maintained under dry, controlled conditions. Proper sealing and environmental control help preserve the physical integrity of the powder and support consistent quality during extended storage.
This material is supplied for formulation, development, and analytical use, and is not intended for direct consumer or clinical application.
Why Choose Us
Shaanxi Medibridge Biotech Co., Ltd. focuses on supplying pharmaceutical raw materials for professional and industrial use, with an emphasis on consistency, documentation readiness, and long-term cooperation. Our telmisartan powder is offered with clearly defined specifications to support formulation development, quality evaluation, and registration-oriented projects.
We maintain stable sourcing and quality control processes to support batch-to-batch consistency. Each supply is accompanied by standard documentation, including COA, with MSDS available upon request, allowing customers to integrate the material into their internal workflows without additional preparation burden.
With experience supporting formulation teams, development projects, and procurement planning, we aim to provide reliable supply rather than short-term availability. Flexible packaging options and responsive communication help ensure that telmisartan powder can be supplied in line with project scale and development timelines.
FAQ
Q: What is telmisartan powder used for?
A: It is used as an active pharmaceutical ingredient in the production of prescription medicines related to blood-pressure regulation, not for direct consumer use.
Q: Is telmisartan powder the same as telmisartan tablets?
A: No, the powder is an active pharmaceutical ingredient used in manufacturing, while tablets are finished dosage forms.
Q: Can telmisartan powder be bought over the counter?
A: No, it is supplied for professional pharmaceutical use.
Q: Is telmisartan powder safe to use directly?
A: No, it is not intended for direct consumer use.
Q: Does telmisartan powder lower blood pressure by itself?
A: It functions as an active ingredient within approved pharmaceutical products.
Hot Tags: telmisartan powder, China telmisartan powder manufacturers, suppliers, factory, apis, Cobicistat Powder, Dicyclanil Powder, Prilocaine Powder, Progesterone Powder, Rapamycin Powder
